Wednesday afternoon Louisiana Attorney General Buddy Caldwell announced that his office has recovered another $38 million from eight pharmaceutical companies he sued for unlawful inflation of drug costs paid by Louisiana taxpayers through the Medicaid program. That brings the amount he has recovered since taking office in 2008 to more than $176 million.

Buddy_Caldwell
Attorney General Buddy Caldwell

The money could not come at a better time for the state's Medicaid program, which has been cut to the bone in recent weeks. All of the proceeds collected through these settlements will go back into the program to assist those who receive benefits.

“I will, as attorney general, continue to aggressively pursue pharmaceutical companies who defraud our Medicaid program,” Caldwell said in Wednesday’s announcement. “We are sending a message to drug companies that their fraud will not be tolerated in Louisiana.”

The eight companies will pay Louisiana a combined total of $38.04 million for misreporting drug price information in order to improperly increase reimbursements paid by Louisiana’s Medicaid program, according to the AG’s office. The Medicaid reimbursements are based on what is called Average Wholesale Prices or AWPs.

Caldwell said these latest AWP settlements result from his 2010 lawsuit against 109 drug manufacturers in the case of State of Louisiana v. Abbott Laboratories, and the related State of Louisiana v. McKesson Corporation case filed last year. The suit accuses the defendants of committing fraud and violating the Louisiana Unfair Trade Practices and Consumer Protection Act and Louisiana’s Medical Assistance Programs Integrity Law.  So far, 13 defendant companies and their subsidiaries have settled with the state for a combined total of $65.2 million in AWP-related recoveries.

Judge Wilson Fields of the 19th Judicial District Court has scheduled the first trial against the remaining defendants to begin in August 2013.

The companies agreeing to the $38 million settlement were:

Teva Pharmaceuticals USA Inc. and Barr Pharmaceutical, Inc. - $20 million

AstraZeneca Pharmaceuticals and MedImmune - $10 million

Amgen Inc. - 2.5 million

Fougera Pharmaceuticals Inc. (formerly Nycomed US) - $ 2 million

Baxter International Inc. and Baxter Healthcare Corporation - $1.2 million

Warner Chilcott Corporation - $1.05 million

Wockhardt USA LLC and Morton Grove Pharmaceuticals - $1 million

Cypress Pharmaceutical Inc. - $235,000

 

 

 

 

 

 

 

To post a comment, please log into your IND account. If you do not have an account, click the "register" button to create one. Facebook comments can be used as an alternative to creating an account at theIND.com.

LA LA Land
Advertisement

Read the Flipping Paper!

Click Here for the Entire Print Version of
IND Monthly
Advertisement
Advertisement